Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.

Cumulative Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Enclomiphene, LGD-4033). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Enclomiphene, LGD-4033). Monitor accordingly.
+
Enclomiphene + LGD-4033
Compatible

Enclomiphene is commonly used as post-cycle therapy (PCT) following LGD-4033 cycles to restore endogenous testosterone production. A typical PCT protocol is 12.5-25 mg/day enclomiphene for 4-6 weeks, starting approximately 2-3 days after the last LGD-4033 dose (the shorter half-life of LGD-4033 compared to RAD-140 means PCT can begin sooner). Some users also run low-dose enclomiphene on-cycle to mitigate suppression, though this approach is less studied.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.